S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58
S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58
S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58
S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58

Q BioMed (QBIO) Stock Forecast, Price & News

+0.01 (+5.67%)
(As of 05/19/2022 03:44 PM ET)
Today's Range
50-Day Range
52-Week Range
465,027 shs
Average Volume
335,728 shs
Market Capitalization
$3.84 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive QBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for Q BioMed and its competitors with MarketBeat's FREE daily newsletter.

Q BioMed logo

About Q BioMed

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.


Q BioMed Inc (QBIO)
Q BioMed outlines strategic direction and goals for 2022
Q BioMed Outlines Strategic Direction for 2022
See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$200 thousand
Book Value
($0.37) per share


Net Income
$-8.24 million
Net Margins
Pretax Margin




Free Float
Market Cap
$3.84 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Q BioMed (OTCMKTS:QBIO) Frequently Asked Questions

Are investors shorting Q BioMed?

Q BioMed saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 3,600 shares, a decline of 91.5% from the April 15th total of 42,600 shares. Based on an average daily trading volume, of 602,300 shares, the short-interest ratio is presently 0.0 days.
View Q BioMed's Short Interest

How were Q BioMed's earnings last quarter?

Q BioMed Inc. (OTCMKTS:QBIO) released its quarterly earnings results on Thursday, April, 14th. The company reported ($0.08) earnings per share for the quarter. The firm had revenue of $0.08 million for the quarter.
View Q BioMed's earnings history

Who are Q BioMed's key executives?
Q BioMed's management team includes the following people:
  • Mr. Denis D. Corin, Chairman, CEO & Pres (Age 49, Pay $300k)
  • Mr. William S. Rosenstadt, Chief Legal Officer, Gen. Counsel & Director (Age 54, Pay $300k)
  • Mr. David Laskow-Pooley, VP of Product Devel. (Age 68)
  • Mr. Robert Derham, VP of Orphan Products
  • Mr. Ari Jatwes, Bus. Devel. Analyst
  • Dr. Amy Ripka, Medicinal Chemistry Advisor
What other stocks do shareholders of Q BioMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Q BioMed investors own include NVIDIA (NVDA), Micron Technology (MU), Washington Trust Bancorp (WASH), Nokia Oyj (NOK), (CGC), Cisco Systems (CSCO), Inovio Pharmaceuticals (INO), Intel (INTC), OPKO Health (OPK) and AT&T (T).

What is Q BioMed's stock symbol?

Q BioMed trades on the OTCMKTS under the ticker symbol "QBIO."

How do I buy shares of Q BioMed?

Shares of QBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Q BioMed's stock price today?

One share of QBIO stock can currently be purchased for approximately $0.11.

How much money does Q BioMed make?

Q BioMed has a market capitalization of $3.84 million and generates $200 thousand in revenue each year. The company earns $-8.24 million in net income (profit) each year or ($0.310010) on an earnings per share basis.

How many employees does Q BioMed have?

Q BioMed employs 3 workers across the globe.

What is Q BioMed's official website?

The official website for Q BioMed is www.qbiomed.com.

How can I contact Q BioMed?

Q BioMed's mailing address is 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017. The company can be reached via phone at (646) 889-2226.

This page was last updated on 5/20/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.